跳至主要内容
临床试验/NCT00399451
NCT00399451Unknown1 期

Preliminary Study on Submucous Sclerosis of Pharynges With 1% Polidocanol to Treat Obstructive Sleep Apnea (OSA) & Snoring Subjects (SS)

Liaoyang Central Hospital0 个研究点目标入组 30 人开始时间: 2006年12月最近更新:
适应症
相关药物

试验速览

阶段
1 期
入组人数
30
主要终点
apnea-hypopnea index (AHI)is on polysomnography(PSG),to compare AHIanterior and posterior treatment.

研究概览

简要总结

The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS & SS,to reduce pharyngeal compliance.

详细描述

Polidocanol submucous sclerosis in the part of pharynges with 1% polidocanol injection.The injection should be in the retropharyngeal submucosa and lateral pharyngeal bands and lateral pharyngeal submucosa and in front submucosa of soft palate.The injection is multi-point,and each point injection is 0.3~0.5ml;the total quantity/each time is not more than 5ml.Every patient have to be treated about 1~2 time.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • OSAS & SS which palatopharyngeal collapse.

排除标准

  • obstructive sleep apnea syndrome (osas) & snoring subjects (ss),which anatomic narrow result in.

结局指标

主要结局

apnea-hypopnea index (AHI)is on polysomnography(PSG),to compare AHIanterior and posterior treatment.

次要结局

  • Arterial oxygen saturation (SaO2) and body mass index (BMI)will be measured on polysomnography

研究者

申办方类型
Other

相似试验